Tag: ReCor Medical
CMS grants transitional pass-through payment for Medtronic’s Symplicity Spyral and Recor’s Paradise renal denervation systems
The Centers for Medicare and Medicaid Services (CMS) has granted transitional pass-through (TPT) pay...
First patients treated in US GPS study of Paradise renal denervation system
The first patients in the USA have been treated in Recor Medical’s Global Paradise System US Pos...
FDA panel votes favourably on safety and efficacy of Paradise renal denervation system
The US Food and Drug Administration (FDA) Circulatory Systems Devices Panel of the Medical Devices A...
ESH guidelines represent a “significant milestone” for hypertension management
ReCor Medical and its parent company Otsuka Medical Devices have welcomed the release of updated...
Results on ReCor Medical’s Paradise ultrasound renal denervation system published in two JAMA Network publications
ReCor Medical and its parent company, Otsuka Medical Devices, recently announced that primary en...
Otsuka Medical Devices and ReCor Medical submit pre-market approval of Paradise ultrasound renal denervation system
Otsuka Medical Devices and ReCor Medical, a subsidiary of Otsuka, announce the filing ...
ReCor Medical announces consistent reduction of blood pressure in pooled analysis of three clinical trials at AHA 2022
ReCor Medical and its parent company, Otsuka Medical Devices, announced consistent and significa...
